Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:21:57 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:XOMA - XOMA ROYALTY CORPORATION EFFE - https://www.xoma.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
XOMA - Q0.140.00·46.240.141.92    42.81  22.30Jun 08Apr 2715 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-04-27 07:00U:XOMANews ReleaseLigand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator
2026-03-18 16:30U:XOMANews ReleaseXOMA Royalty Declares Quarterly Preferred Stock Dividends
2026-03-18 06:00U:XOMANews ReleaseXOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
2026-03-12 06:30U:XOMANews ReleaseXOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
2026-02-18 16:30U:XOMANews ReleaseXOMA Royalty to Present at Investor Conferences in March
2026-02-09 09:53U:XOMANews ReleaseXOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
2026-01-12 07:30U:XOMANews ReleaseXOMA Royalty Announces CFO Transition
2025-12-30 07:30U:XOMANews ReleaseXOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
2025-12-22 07:30U:XOMANews ReleaseXOMA Royalty Declares Quarterly Preferred Stock Dividends
2025-12-15 17:00U:XOMANews ReleaseXOMA Royalty Enters into Agreement to Acquire Generation Bio
2025-12-05 09:00U:XOMANews ReleaseXOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
2025-12-05 07:45U:XOMANews ReleaseMural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition
2025-11-26 09:00U:XOMANews ReleaseMural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
2025-11-21 07:45U:XOMANews ReleaseXOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
2025-11-12 07:30U:XOMANews ReleaseXOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
2025-11-10 16:09U:XOMANews ReleaseLAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
2025-10-24 16:26U:XOMANews ReleaseMural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
2025-10-17 11:45U:XOMANews ReleaseXOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
2025-10-02 16:43U:XOMANews ReleaseXOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.